Ongoing Care Team Support: Weight management is a journey, not a one-time event
Important Note : If you have heart failure, chronic kidney disease, or liver disease, follow your healthcare provider's specific guidance on fluid intake, as these conditions may require fluid restriction rather than increased consumption
Retatrutide cannot currently be legally prescribed or sold as a finished drug product for individual use
If you have already achieved significant weight loss and are in a maintenance phase, you may be able to reduce your dose to a level that is more affordable at out-of-pocket prices
Prepare your Injection Site: Wipe your desired injection area with alcohol and let it dry
Semaglutide (Wegovy), when used at the 2.4 mg weekly dose for weight management, has demonstrated significant efficacy in large-scale randomised controlled trials